Search research articles
Contact Us
Filters
Showing results (201-210 of 215) with videos related to
Page
of 22
Sort By:
Journal of Gastrointestinal and Liver Diseases : JGLD
|
June 30, 2024
The Staging of Newly Diagnosed Hepatocellular Carcinoma in Romania. A National Multicentric Study
Rareș Crăciun, Horia Ștefănescu, Ioan Sporea, et al.
Viruses
|
January 25, 2025
Unveiling Prevalence, Risk Factors, and Outcomes of Hepatitis D Among Vulnerable Communities in Romania
Liana Gheorghe, Speranta Iacob, Irma Eva Csiki, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
August 10, 2021
Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry
Ana-Maria Singeap, Irina Girleanu, Mircea Diculescu, et al.
Medicine
|
February 3, 2018
Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older
Anca Trifan, Carol Stanciu, Liana Gheorghe, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
December 19, 2017
New Epidemiologic Data Regarding Hepatitis C Virus Infection in Romania
Mircea Manuc, Carmen M Preda, Corneliu P Popescu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 18, 2017
Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis
Carmen M Preda, Corneliu P Popescu, Cristian Baicus, et al.
Journal of Clinical Medicine
|
May 4, 2026
Efficacy of Second-Line Advanced Therapy in Patients with Crohn's Disease After Failure of a First Anti-TNF: A Descriptive Analysis
Corina Meianu, Carmen Monica Preda, Mircea Diculescu, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
December 29, 2024
Effectiveness of 8-week Treatment with Glecaprevir/Pibrentasvir in Treatment-naïve or -experienced HCV Patients: Results from an Observational Retrospective Study in Real-life Settings (ODYSSEY)
Anca Trifan, Carol Stanciu, Adrian Streinu-Cercel, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
June 28, 2025
The Role of Easy-to-use Non-invasive Scores in the Assessment of Hepatocellular Carcinoma Prognosis - Data from the Romanian Hepatocellular Carcinoma Registry
Dana Crișan, Bogdan Procopeț, Rareș Crăciun, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie
|
January 7, 2024
Improvement of carotid atherosclerosis and peripheral artery disease after hepatitis C virus eradication by direct-acting antivirals
Tudor Cuciureanu, Carol Stanciu, Robert Radu Năstasă, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 215) with videos related to
Sort By:
Page
of 22
Journal of Gastrointestinal and Liver Diseases : JGLD
|
June 30, 2024
The Staging of Newly Diagnosed Hepatocellular Carcinoma in Romania. A National Multicentric Study
Rareș Crăciun, Horia Ștefănescu, Ioan Sporea, et al.
Viruses
|
January 25, 2025
Unveiling Prevalence, Risk Factors, and Outcomes of Hepatitis D Among Vulnerable Communities in Romania
Liana Gheorghe, Speranta Iacob, Irma Eva Csiki, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
August 10, 2021
Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry
Ana-Maria Singeap, Irina Girleanu, Mircea Diculescu, et al.
Medicine
|
February 3, 2018
Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older
Anca Trifan, Carol Stanciu, Liana Gheorghe, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
December 19, 2017
New Epidemiologic Data Regarding Hepatitis C Virus Infection in Romania
Mircea Manuc, Carmen M Preda, Corneliu P Popescu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 18, 2017
Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis
Carmen M Preda, Corneliu P Popescu, Cristian Baicus, et al.
Journal of Clinical Medicine
|
May 4, 2026
Efficacy of Second-Line Advanced Therapy in Patients with Crohn's Disease After Failure of a First Anti-TNF: A Descriptive Analysis
Corina Meianu, Carmen Monica Preda, Mircea Diculescu, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
December 29, 2024
Effectiveness of 8-week Treatment with Glecaprevir/Pibrentasvir in Treatment-naïve or -experienced HCV Patients: Results from an Observational Retrospective Study in Real-life Settings (ODYSSEY)
Anca Trifan, Carol Stanciu, Adrian Streinu-Cercel, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
June 28, 2025
The Role of Easy-to-use Non-invasive Scores in the Assessment of Hepatocellular Carcinoma Prognosis - Data from the Romanian Hepatocellular Carcinoma Registry
Dana Crișan, Bogdan Procopeț, Rareș Crăciun, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie
|
January 7, 2024
Improvement of carotid atherosclerosis and peripheral artery disease after hepatitis C virus eradication by direct-acting antivirals
Tudor Cuciureanu, Carol Stanciu, Robert Radu Năstasă, et al.
Page
of 22